Doxycycline 40mg capsules (30mg Immediate-Release10mg Delayed-Release Beads): Anti-inflammatory dose in Rosacea

American Journal of Clinical Dermatology

Volumn 11, Issue 3, 2010, Pages 217-222

  McKeage, Kate ^a   Deeks, Emma D ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

Adis Drug Profiles; Adverse reactions; Doxycycline; Pharmacodynamics; Pharmacokinetics; Rosacea; Therapeutic use

Indexed keywords

DOXYCYCLINE; METRONIDAZOLE; PLACEBO; TETRACYCLINE; ANTIINFLAMMATORY AGENT;

ABDOMINAL PAIN; ANTIINFLAMMATORY ACTIVITY; CLINICAL TRIAL; DIARRHEA; DRUG CAPSULE; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ESOPHAGUS PAIN; HEADACHE; HUMAN; INFLUENZA; LABORATORY TEST; MORNING DOSAGE; NAUSEA; PHOTOSENSITIVITY; PRIORITY JOURNAL; REVIEW; RHINOPHARYNGITIS; ROSACEA; SIDE EFFECT; URTICARIA; VITAL SIGN; VOMITING; WEIGHT CHANGE; ARTICLE; DOSE RESPONSE;

ANTI-INFLAMMATORY AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXYCYCLINE; HUMANS; ROSACEA;

EID: 77950680217     PISSN: 11750561     EISSN: 11791888     Source Type: Journal    
DOI: 10.2165/11204850-000000000-00000     Document Type: Review

References (19)

1. The National Rosacea Society. Information for patients [online]. Available from URL: http://www.rosacea.org/patients/index.php [Accessed 2010 Jan 21]
2. Korting HC, Schollmann C. Current topical and systemic approaches to treatment of rosacea. J Eur Acad Dermatol Venereol 2009 Aug; 23 (8): 876-882
3. Fowler Jr JF. Anti-inflammatory dose doxycycline for the treatment of rosacea. Expert Rev Dermatol 2007; 2 (5): 523-531
4. American Acne and Rosacea Society. Rosacea medical management guidelines [online]. Available from URL: http://www.acnesociety.org/files/public/AARS- Rosacea-Guidelines.pdf [Accessed 2010 Jan 20]
5. Millikan L. The proposed inflammatory pathophysiology of rosacea: implications for treatment. Skinmed 2003; 2 (1): 43-47
6. Jones D. Reactive oxygen species and rosacea. Cutis 2004 Sep; 74 (3 Suppl): 17-20, 32-34
7. Galderma Laboratories L.P. Oracea (doxycycline, USP) capsules 40 mg. Prescribing information [online]. Available from URL: http://hcp.oracea.com/ Includes/PDF/PrescribingInformation.pdf [Accessed 2010 Jan12]
8. Akamatsu H, Asada M, Komura J, et al. Effect of doxycycline on the generation of reactive oxygen species: a possible mechanism of action of acne therapy with doxycycline. Acta Derm Venereol 1992; 72 (3): 178-179
9. Jain A, Sangal L, Basal E, et al. Anti-inflammatory effects of erythromycin and tetracycline on Propionibacterium acnes induced production of chemotactic factors and reactive oxygen species by human neutrophils. Dermatol Online J 2002 Oct; 8 (2): 2
10. Amin AR, Attur MG, Thakker GD, et al. A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc Natl Acad SciUS A 1996 Nov 26; 93 (24): 14014-14019
11. Golub LM, Lee HM, Ryan ME, et al. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res 1998 Nov; 12 (2): 12-26
12. Ryan ME, Usman A, Ramamurthy NS, et al. Excessive matrix metalloproteinase activity in diabetes: inhibition by tetracycline analogues with zinc reactivity. Curr Med Chem 2001 Feb; 8 (3): 305-316
13. Webster GF, Toso SM, Hegemann L. Inhibition of a model of in vitro granuloma formation by tetracyclines and ciprofloxacin: involvement of protein kinase C. Arch Dermatol 1994 Jun; 130 (6): 748-752
14. Preshaw PM, Novak MJ,Mellonig J, et al. Modified-release subantimicrobial dose doxycycline enhances scaling and root planing in subjects with periodontal disease. J Periodontol 2008; 79: 440-452
15. European Medicines Agency. Oracea 40 mg modified-release hard capsules: summary of product characteristics [online]. Available from URL: http:// www.ema.europa.eu/pdfs/human/referral/oracea/oracea-annexI-IV-en.pdf [Accessed 2010 Jan 18]
16. Theobald K, Bradshaw M, Leyden J. Anti-inflammatory dose doxycycline (40 mg controlled-release) confers maximum anti-inflammatory efficacy in rosacea. Skinmed 2007 Sep 31; 6 (5): 221-226
17. Del Rosso JQ, Webster GF, Jackson M, et al. Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea. J Am Acad Dermatol 2007 May; 56 (5): 791-802
18. Fowler Jr JF. Combined effect of anti-inflammatory dose doxycycline (40-mg doxycycline, USP monohydrate controlled-release capsules) and metronidazole topical gel 1% in the treatment of rosacea. J Drugs Dermatol 2007 Jun; 6 (6): 641-645
19. Del Rosso JQ, Schlessinger J, Werschler P. Comparison of anti-inflammatory dose doxycycline versus doxycycline 100 mg in the treatment of rosacea. J Drugs Dermatol 2008 Jun; 7 (6): 573-576